Chapter 01: Introduction to Pathophysiology
b b b b
VanMeter and Hubert: Gould’s Pathophysiology for the Health Professions, 7th Edition
b b b b b b b b b b
MULTIPLEbCHOICE
1. Whichbofbthebfollowingbwouldbbebthebmostblikelybcausebofbanbi
atrogenicbdisease?
a. Anbinheritedbdisorder
b. Abcombinationbofbspecificbetiologicalbfactors
c. Anbunwantedbeffectbofbabprescribedbdrug
d. Prolongedbexposurebtobtoxicbchemicalsbinbthebenvironment
ANS:b C
2. Thebmanifestationsbofbabdiseasebarebbestbdefinedbasbthe
a. subjectivebfeelingsbofbdiscomfortbduringbabchronicbillness.
b. signsbandbsymptomsbofbabdisease.
c. factorsbthatbprecipitatebanbacutebepisodebofbabchronicbillness.
d. earlybindicatorsbofbthebprodromalbstagebofbinfection.
ANS:b B
3. Thebbestbdefinitionbofbthebtermbprognosisbisbthe
a. precipitatingbfactorsbcausingbanbacutebepisode.
b. numberbofbremissionsbtobbebexpectedbduringbthebcoursebofbabchronicbillness.
c. predictedboutcomeborblikelihoodbofbrecoverybfrombabspecificbdisease.
d. exacerbationsboccurringbduringbchronicbillness.
ANS:b C
4. Whichbofbthebfollowingbisbconsideredbabsystemicbsignbofbdisease?
a. Swellingbofbthebknee
b. Fever
c. Painbinbthebneck
d. Redbrashbonbthebface
ANS:b B
5. Etiologybisbdefinedbasbthebstudybofbthe
a. causesbofbabdisease.
b. coursebofbabdisease.
c. expectedbcomplicationsbofbabdisease.
d. manifestationsbofbabdisease.
ANS:b A
6. Abtypebofbcellularbadaptationbinbwhichbtherebisbabdecreasebinbcellbsizebisbreferredbtobas
a. hypertrophy.
b. metaplasia.
c. anaplasia.
d. atrophy.
ANS:b D
7. Abchangebinbabtissuebmarkedbbybcellsbthatbvarybinbsizebandbshapebandbshowbincreasedbmitoticbfi
guresbwouldbbebcalled
,TestbBankbForbGould'sbPathophysiologybforbthebHealthbProfessionsb7thbEditionbVanMeter 2
a. metaplasia.
b. atrophy.
c. dysplasia.
d. hypertrophy.
ANS:b C
8. Abdeficitbofboxygenbinbthebcellsbusuallybduebtobrespiratoryborbcirculatorybproblemsbisbcalled
a. apoptosis.
b. ischemia.
c. hypertrophy.
d. necrosis.
ANS:b B
9. Whenbabgroupbofbcellsbinbthebbodybdies,bthebchangebisbcalled
a. ischemia.
b. gangrene.
c. hypoxia.
d. necrosis.
ANS:b D
10. Rigorousbweightlifting/bodybbuildingbregimensbmaybresultbinbthebskeletalbmusclebcellsb
undergoing
a. hypertrophy.
b. dysplasia.
c. atrophy.
d. regeneration.
ANS:b A
11. Thebtermbcancerbrefersbto
a. dysplasia.
b. hyperplasia.
c. metaplasia.
d. malignantbneoplasm.
ANS:b D
12. Tobwhichbofbthebfollowingbdoesbthebtermbapoptosisbrefer?
a. Increasedbratebofbmitosisbbybcertainbcells
b. Ischemicbdamagebtobcells
c. Liquefactionbofbnecroticbtissue
d. Preprogrammedbcellbself-destruction
ANS:b D
13. WhichbofbthebfollowingbstatementsbisbTRUE?
a. AlterationbofbDNAbdoesbnotbchangebcellbfunction.
b. Damagedbcellsbmaybbebablebtobrepairbthemselves.
c. Allbtypesbofbcellsbdiebatbthebsamebrate.
d. Mildbischemiabcausesbimmediatebcellbdeath.
ANS:b B
14. Caseationbnecrosisbrefersbtobanbareabwhere
a. cellbproteinsbhavebbeenbdenatured.
,TestbBankbForbGould'sbPathophysiologybforbthebHealthbProfessionsb7thbEditionbVanMeter 3
b. cellsbarebliquefiedbbybenzymes.
c. deadbcellsbformbabthickbcheesybsubstance.
d. bacterialbinvasionbhasboccurred.
ANS:b C
15. Routinebapplicationbofbsunbblockbtobskinbwouldbbebanbexamplebof
a. anbiatrogenicbcausebofbcancer.
b. abpreventivebmeasure.
c. abprecipitatingbfactor.
d. abpredisposingbcondition.
ANS:b B
16. Abcircumstancebthatbcausesbabsuddenbacutebepisodebofbabchronicbdiseasebtoboccurbisbtermed
a. latentbstage.
b. predisposingbfactor.
c. incidence.
d. precipitatingb factor.
ANS:b D
17. Thebtermbhomeostasisbrefersbto
a. thebcausativebfactorsbinbabparticularbdisease.
b. maintenancebofbabstablebinternalbenvironment.
c. abconditionbthatbtriggersbanbacutebepisode.
d. abcollectionbofbsignsbandbsymptoms.
ANS:b B
18. Whichbtermbisbusedbtobdescribebabnewbandbsecondaryborbadditionalbproblembthatbarisesbafterbthebo
riginalbdiseasebhasbbeenbestablished?
a. Symptoms
b. Occurrence
c. Manifestations
d. Complication
ANS:b D
19. Pathophysiologybinvolvesbthebstudybof
a. thebstructurebofbthebhumanbbody.
b. thebfunctionsbofbvariousborgansbinbthebbody.
c. functionalborbstructuralbchangesbresultingbfrombdiseasebprocesses.
d. variousbcellbstructuresbandbrelatedbfunctions.
ANS:b C
20. Whichbofbthebfollowingbisbthebbestbdefinitionbofbepidemiology?
a. Thebsciencebofbtrackingbtheboccurrencebandbdistributionbofbdiseases
b. Thebrelativebnumberbofbdeathsbresultingbfrombabparticularbdisease
c. Identificationbofbabspecificbdiseasebthroughbevaluationbofbsignsbandbsymptoms
d. Thebglobalbsearchbforbemergingbdiseases
ANS:b A
, TestbBankbForbGould'sbPathophysiologybforbthebHealthbProfessionsb7thbEditionbVanMeter 4
21. Whichbofbthebfollowingbcanbcausebcellbinjuryborbdeath?
1. Hypoxia
2. Exposurebtobexcessivebcold
3. Excessivebpressurebonbabtissue
4. Chemicalbtoxins
a. 1,b2
b. 2,b4
c. 1,b3,b4
d. 1,b2,b3,b4
ANS:b D
22. AllbofbthebfollowingbarebpartbofbthebSevenbStepsbtobHealthbEXCEPT:
a. Followbcancerbscreeningbguidelines.
b. Usebsunbblockbagentsbwheneverbexposed.
c. Participatebinbstrenuousbexercisebonbabregularbdailybbasis.
d. Choosebhighbfiber,blowerbfatbfoods.
ANS:b C
23. Thebtermbdiseasebrefersbto
a. thebperiodbofbrecoverybandbreturnbtobabnormalbhealthybstate.
b. abdeviationbfrombthebnormalbstatebofbhealthbandbfunction.
c. thebtreatmentbmeasuresbusedbtobpromotebrecovery.
d. abbasicbcollectionbofbsignsbandbsymptoms.
ANS:b B
24. Abcollectionbofbsignsbandbsymptoms,boftenbaffectingbmorebthanboneborganborbsystem,bthatbu
suallyboccurbtogetherbinbresponsebtobabcertainbconditionbisbreferredbtobasba(an)
a. acutebdisease.
b. multiorganbdisorder.
c. syndrome.
d. manifestation.
ANS:b C
25. AllbofbthebfollowingbstatementsbarebcorrectbaboutbcellbdamagebEXCEPT:
a. Thebinitialbstagebofbcellbdamageboftenbcausesbanbalterationbinbmetabolicbreactions.
b. Ifbthebfactorbcausingbthebdamagebisbremovedbquickly,bthebcellbmaybbebablebtobr
ecoverbandbreturnbtobitsbnormalbstate.
c. Ifbthebnoxiousbfactorbremainsbforbanbextendedbperiodbofbtime,bthebdamagebbecomesbi
rreversiblebandbthebcellbdies.
d. Initially,bcellbdamagebdoesbnotbchangebcellbmetabolism,bstructure,borbfunction.
ANS:b D
26. Whichbofbthebfollowingbconditionsbdistinguishesbdoublebblindbstudiesbusedbinbhealthbresearch?
a. Neitherbthebmembersbofbthebcontrolbgroupborbthebexperimentalbgroupbnorbthebpersonba
dministeringbthebtreatmentbknowsbwhobisbreceivingbthebexperimentalbtherapy.
b. Bothbgroupsbofbresearchbsubjectsbandbthebpersonbadministeringbthebtreatmentbknowbwhobi
sbreceivingbthebexperimentalbtherapy.
c. Thebresearchbsubjectsbdobnotbknow,bbutbthebpersonbadministeringbthebtreatmentb
knowsbwhobisbreceivingbplaceboborbstandardbtherapy.
d. Onlybmembersbofbthebcontrolbgroupbknowbtheybarebreceivingbstandardbtherapy.